NanomediGene Revenue

Biotechnology Research • Hoover, Alabama, United States • 1-10 Employees

NanomediGene revenue & valuation

Annual revenue	$85,555
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$273,776
Total funding	No funding

Key Contact at NanomediGene

Yasin Oduk

Chief Executive Officer

Company overview

Headquarters	1 Chase Corporate Dr, 400L, Birmingham, Alabama 35244, US
Phone number	+12053136303
Website	nanomedigene.com
Founded	2019
Employees	1-10
Socials

NanomediGene Email Formats

NanomediGene uses 1 email format. The most common is {first initial} (e.g., j@nanomedigene.com), used 100% of the time.

Format	Example	Percentage
{first initial}	j@nanomedigene.com	100%

About NanomediGene

NanomediGene is a biotechnology company engaged in the development and design of targeted drug delivery systems of proteins, drug molecules, genes and cellular-based therapies with innovations applicable to many medical diseases including cancers. Our current projects focus on kidney, heart and lung diseases.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

C-Suite

Employees by Department

NanomediGene has 1 employees across 1 departments.

Departments

Number of employees

Funding Data

NanomediGene has never raised funding before.

NanomediGene Tech Stack

Discover the technologies and tools that power NanomediGene's digital infrastructure, from frameworks to analytics platforms.

SiteGround

Hosting

AddToAny Share Buttons

WordPress plugins

Swiper

JavaScript libraries

lit-element

JavaScript libraries

Google Maps

Maps

lit-html

JavaScript libraries

MonsterInsights

Analytics

jQuery Migrate

JavaScript libraries

Twitter Emoji

Font scripts

jQuery

JavaScript libraries

PHP

Programming languages

WordPress

Blogs

Frequently asked questions

NanomediGene is located in Hoover, Alabama, US.

You can reach NanomediGene at +12053136303.

NanomediGene generates an estimated annual revenue of $85,555. This revenue figure reflects the company's market position and business performance in its industry.

NanomediGene has an estimated valuation of $273,776. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

NanomediGene was founded in 2019, making it 7 years old. The company has established itself as a significant player in its industry over this time.

NanomediGene has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contact at NanomediGene

Yasin Oduk

Chief Executive Officer

4.8

40,000 users